Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|February 1, 1987
Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemiaP A Cassileth, C B Begg, R Silber, et al.
Scandinavian Journal of Haematology|January 1, 1985
T-cell chronic lymphocytic leukaemia: anomalous cell markers, variable morphology, and marked responsiveness to pentostatin (2'-deoxycoformycin)A S Spiers, M P Davis, M Levine, et al.
Blood|April 15, 1992
Varying intensity of postremission therapy in acute myeloid leukemiaP A Cassileth, E Lynch, J D Hines, et al.
Blood|July 15, 1995
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)J M Rowe, J W Andersen, J J Mazza, et al.
Thorax|September 13, 2013
Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective studyPierre-Olivier Bridevaux, J-D Aubert, P M Soccal, et al.
Leukemia|January 1, 1992
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology GroupP A Cassileth, J W Andersen, J M Bennett, et al.
American Journal of Clinical Oncology|April 1, 1995
The treatment of older adult patients with acute myeloid leukemia by triple infusion chemotherapyW R Friedenberg, H J Miller, J J Marx, et al.
JAMA|November 18, 1983
Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacementR D Sautter, E L Koch, W O Myers, et al.
Haematologica|July 28, 2006
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemiaMark R Litzow, Sandra Lee, John M Bennett, et al.
Acta Haematologica|July 24, 2019
Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)Sanford Kempin, Zhuoxin Sun, Neil E Kay, et al.
Pageof 11